ArticleEJIFCC2025
Exploring Genetic Variability in VDR FokI and BsmI Polymorphisms and Their Association with Rheumatoid Arthritis.
Article in EJIFCC, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Role of Vitamin D in Autoimmune Diseases.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rheumatoid Arthritis (RA) is a chronic, inflammatory autoimmune disease that mainly affects small joints and progresses to larger joints. It impacts approximately 1% of the global population, with women being three times more likely to develop it than men, typically between ages 40 and 50. Genetic and environmental factors, including vitamin D deficiency, contribute to RA development. The vitamin D receptor (VDR) gene plays a crucial role in regulating metabolism and inflammation, making it a key candidate in RA. Aims: This study determines the relationship between VDR FokI (rs10735810) and VDR BsmI (rs1544410) gene polymorphisms in RA patients and healthy controls. Methods: A total of 400 participants were included in the study, consisting of 200 RA patients and 200 healthy controls. Genetic varations of VDR genes was performed using the PCR-RFLP technique. Result: Among 200 RA patients, 42 (21%) were male and 158 (79%) were female, while in the control group, 40 (20%) were male and 160 (80%) were female. The average age of RA patients was 43±17 years and a mean disease onset at age 30.3±19.3 years. The Ff and ff genotypes of the FokI polymorphism were significantly more frequent in RA patients (OR=1.8, p=0.011 and OR=2.8, p=0.004, respectively). For the BsmI polymorphism, the Bb genotype showed a significant association with RA (OR=1.5, p=0.049), while the bb genotype did not (OR=1.4, p=0.241). Gender-based analysis revealed higher frequencies of the Ff, ff, and bb genotypes in females, with significant associations for Ff (OR=3.0, p=0.009), ff (OR=4.5, p=0.002) for Bsml genotype only bb (OR=3.9, p=0.006) was significantly increase the risk of RA. Conclusions: This study concluded that the VDR FokI (rs10735810) gene polymorphism was associated with RA, while the VDR BsmI (rs1544410) polymorphism did not appear to have a significant association with the disease.
Indexed as
Identifiers
41098217PMC12519643What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.